65 I B, drugs, pharmaceuticals,&hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79720D0225
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 88% complete
IDV ceiling
$12,000,000,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs issued a Federal Supply Schedule contract to Novartis Innovative Technologies Inc. under Pharmaceuticals and Drugs (FSS-61-IB) effective September 15, 2020, with a ceiling value of twelve billion dollars and performance through September 14, 2027.

The contract covers Schedule 65 I B, Drugs, Pharmaceuticals, and Hematology Related Products under the multiple-award Federal Supply Schedule vehicle, permitting VA and other federal agencies to issue orders directly against Novartis's price list for pharmaceutical and hematology products without conducting new competitions for each transaction. Place of performance is nationwide.

Transactions

Action Obligated Date
Novation Agreement P00023 · ADM name change $0
Supplemental Agreement for work within scope P00022 · ADM extension $0
Supplemental Agreement for work within scope P00021 · 42-2A PL lifecycle 1 NDC $0
Supplemental Agreement for work within scope P00020 · ADM evergreen $0
Supplemental Agreement for work within scope P00019 · 42-2A PL lifecycle $0
Supplemental Agreement for work within scope P00017 · Addition. $0
Supplemental Agreement for work within scope P00016 · 42-2A 2026 PL update $0
Supplemental Agreement for work within scope P00018 · 42-2A public law lifecycle $0
Supplemental Agreement for work within scope P00015 · ADM sub plans $0
Other Administrative Action P00014 · ADM signature authority and address change $0
Supplemental Agreement for work within scope P00013 · ADM extension $0
Supplemental Agreement for work within scope P00012 · 42-2A 2025 PL $0
Supplemental Agreement for work within scope P00010 · ADM subcontracting plans $0
Other Administrative Action P00011 · ADM POC update $0
Other Administrative Action P00009 · ADM update signature authority $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 · Pharmaceuticals $0
Vendor DUNS or Name Change - Non-Novation P00003 · 65IB drugs, pharmaceuticals and hematology related products $0
Other Administrative Action P00002 · 61IB drugs, pharmaceuticals and hematology related products $0
Supplemental Agreement for work within scope P00001 · 65IB drugs, pharmaceuticals and hematology related products $0
Original award $0
Show all 24

Quick answers

Who was awarded contract 36F79720D0225?

36F79720D0225 was awarded to Novartis Innovative Technologies Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2020.

How much is contract 36F79720D0225 worth?

36F79720D0225's own ceiling is $12,000,000,000.

Who can order from contract 36F79720D0225?

36F79720D0225 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79720D0225 part of a contract vehicle?

Yes. 36F79720D0225 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79720D0225 competed?

The extent of competition for 36F79720D0225 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV